Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 21861 - 21880 out of 485350 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Pharmacor) 1 g/5 mL powder for oral liquid, 165 mL | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmacorPtyLimited |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Pharmacor) 1 g/5 mL powder for oral liquid, 165 mL | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmacorPtyLimited |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Pharmacor) 1 g/5 mL powder for oral liquid, 165 mL | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmacorPtyLimited |
| Australia | (L04AA06) mycophenolic acid | Cellcept 1 g/5 mL powder for oral liquid, 165 mL | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | RocheProductsPtyLtd |
| Australia | (L04AA06) mycophenolic acid | Cellcept 1 g/5 mL powder for oral liquid, 165 mL | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | RocheProductsPtyLtd |
| Australia | (L04AA06) mycophenolic acid | Cellcept 1 g/5 mL powder for oral liquid, 165 mL | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | RocheProductsPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
Pages
